Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas

Zhi-hua Ye1 Department of Pathology

Li Gao1 Department of Pathology

Dong-yue Wen2 Department of Ultrasonography, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People’s Republic of China

Yun He2 Department of Ultrasonography, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People’s Republic of China

Yu-yan Pang1 Department of PathologyCorrespondence[email protected] [email protected]

Gang Chen1 Department of PathologyCorrespondence[email protected] [email protected]

Pages 1711-1723 | Published online: 21 Mar 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
PubMed Web of Science ®Google Scholar
ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
PubMed Web of Science ®Google Scholar
VenookAPPapandreouCFuruseJde GuevaraLLThe incidence and epidemiology of hepatocellular carcinoma: a global and regional perspectiveOncologist201015suppl 4513
PubMed Web of Science ®Google Scholar
WhiteDLThriftAPKanwalFDavilaJEl-SeragHBIncidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012Gastroenterology Epub20161123
Google Scholar
BaloghJVictorD3rdAshamEHHepatocellular carcinoma: a reviewJ Hepatocell Carcinoma20163415327785449
PubMed Web of Science ®Google Scholar
ColagrandeSInghilesiALAburasSTalianiGGNardiCMarraFChallenges of advanced hepatocellular carcinomaWorld J Gastroenterol201622347645765927678348
PubMed Web of Science ®Google Scholar
JanssensSBeyaertRFunctional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family membersMol Cell200311229330212620219
PubMed Web of Science ®Google Scholar
LiNJiangJFuJTargeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinomaJ Exp Clin Cancer Res201635114027619757
PubMedGoogle Scholar
CaoZHenzelWJGaoXIRAK: a kinase associated with the interleukin-1 receptorScience19962715252112811318599092
PubMedGoogle Scholar
FlannerySBowieAGThe interleukin-1 receptor-associated kinases: critical regulators of innate immune signallingBiochem Pharmacol201080121981199120599782
PubMed Web of Science ®Google Scholar
WescheHHenzelWJShillinglawWLiSCaoZPillars article: MyD88: an adapter that recruits IRAK to the IL-1 receptor complexImmunity199778378479430229
PubMed Web of Science ®Google Scholar
J Immunol2013190151523264669
PubMedGoogle Scholar
GuhaMMackmanNLPS induction of gene expression in human monocytesCell Signal2001132859411257452
PubMed Web of Science ®Google Scholar
ZhangGGhoshSToll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunityJ Clin Invest20011071131911134172
PubMed Web of Science ®Google Scholar
RhyasenGWBolanosLFangJTargeting IRAK1 as a therapeutic approach for myelodysplastic syndromeCancer Cell20132419010423845443
PubMed Web of Science ®Google Scholar
SrivastavaRGengDLiuYAugmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4Cancer Res201272236209621623041547
PubMedGoogle Scholar
BehrensCFengLKadaraHExpression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesionsClin Cancer Res2010161344420028769
PubMedGoogle Scholar
ZhangXDangYLiPRongMChenGExpression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray studyInt J Clin Exp Pathol20147118096810425550857
PubMed Web of Science ®Google Scholar
ScheerenFAKuoAHvan WeeleLJA cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesisNat Cell Biol201416121238124825362351
PubMedGoogle Scholar
WeeZNYatimSMKohlbauerVKIRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelNat Commun20156874626503059
PubMed Web of Science ®Google Scholar
LiJJLuoJLuJNRelationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro studyCancer Cell Int2016167627708550
PubMedGoogle Scholar
LiJLiangLLiuYClinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosisOnco Targets Ther201691721173427051307
PubMed Web of Science ®Google Scholar
GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269 pl1
Web of Science ®Google Scholar
CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
PubMed Web of Science ®Google Scholar
LiZYoungerKGartenhausRInhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapiesJ Clin Invest201512531081109725642772
PubMedGoogle Scholar
O’NeillLAGolenbockDBowieAGThe history of toll-like receptors – redefining innate immunityNat Rev Immunol201313645346023681101
PubMed Web of Science ®Google Scholar
Rakoff-NahoumSMedzhitovRToll-like receptors and cancerNat Rev Cancer200991576319052556
PubMed Web of Science ®Google Scholar
FonteEAgathangelidisAReverberiDToll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferationHaematologica2015100111460146826294727
PubMedGoogle Scholar
KogoRMimoriKTanakaFKomuneSMoriMClinical significance of miR-146a in gastric cancer casesClin Cancer Res201117134277428421632853
PubMed Web of Science ®Google Scholar
LiYVandenboomTG2ndWangZmiR-146a suppresses invasion of pancreatic cancer cellsCancer Res20107041486149520124483
PubMed Web of Science ®Google Scholar
BhaumikDScottGKSchokrpurSPatilCKCampisiJBenzCCExpression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cellsOncogene200827425643564718504431
PubMed Web of Science ®Google Scholar
YangDChenWXiongJSherrodCJHenryDHDittmerDPInterleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphomaProc Natl Acad Sci U S A201411144E4762E476825341731
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date